Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Effects of four regimens on subclinical atherosclerosis in newly diagnosed type 2 diabetic patients

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Subclinical atherosclerosis evaluated by high resolution ultrasonography in patients with newly diagnosed type 2 diabetes mellitus un-dergoing intensive treatment

Effect of Multifactorial Intervention on Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetes

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Effect of Vitamin E on Subclinical Atherosclerosis in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Effect of Rosuvastatin on the Change of Th1/Th2 Subsets in Coronary Heart Disease with Diabetes

Risk Factors for the Progress of Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetics with Multifactorial Intervention

Long-Term Effects Intensive Medical Therapy on the Development and Progression of Subclinical Atherosclerosis and the Metabolic Syndrome in Chinese Patients with Type 2 Diabetes Mellitus

Impact of Multifactorial Intervention on Subclinical Atherosclerosis in Patients with Newly-diagnosed Type 2 Diabetes

Effect of Intensive Treatment on Subclinical Atherosclerosis in Patients with Newly Diagnosed Type 2 Diabetes Mellitus by High Resolution Ultrasonography

Effect of Baseline Systolic Blood Pressure on New-Onset Cardioand Cerebrovascular Events in Diabetic Population

The prevalence of subclinical atherosclerosis and its risk factors in the newly diagnosed type 2 diabetes

Effects of Multifactorial Intervention of Metabolic Syndrome in Newly-Diagnosed Type 2 Diabetics

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.

Effects of Regular Physical Activity on Glucose and Lipid Control in Chinese Type 2 Diabetic Patients: a Meta-Analysis

Effects of Vitamin D3 Supplementation Combined with Standardized Hypoglycemic Regimen on Islet Β Cell Function and Macrovascular Complications in Newly Diagnosed Type 2 Diabetes Mellitus

[Studies of Influences of Blood Glucose Controlling on the Changes of Lipid Profiles, ApoB100, ApoAI and HDL Subclass of Newly Diagnosed Type 2 Diabetes].

Study of the Relationship Between Blood Glucose Fluctuation and Subclinical Atherosclerosis in Type 2 Diabetes Mellitus

[Effect of acupuncture for regulating spleen and stomach on aspirin resistance in patients with type 2 diabetes mellitus: a randomized controlled trial]